Stover Liz, Chi Jessica, Kelsberg Gary, Safranek Sarah
Valley Family Medicine Residency, University of Washington at Renton, WA, USA.
University of Washington Health Sciences Library, Seattle, WA, USA.
J Fam Pract. 2016 Nov;65(11):832-834.
In patients with metabolic syndrome who are in the highest-risk quartile for progression to diabetes (predicted mean 3-year risk, 60%), metformin, 850 mg twice daily, reduces the absolute risk by about 20% over a 3-year period. Metformin doesn't reduce the incidence in patients at lower risk of progression.
在代谢综合征患者中,处于进展为糖尿病最高风险四分位数的患者(预测平均3年风险为60%),二甲双胍每日两次,每次850毫克,在3年期间可使绝对风险降低约20%。二甲双胍不会降低进展风险较低患者的发病率。